In addition, the proliferative capacity of cancer cell lines with oncogenic KRAS was less affected than that of normal cells when challenged with soft matrix growth conditions, suggesting that oncogenic RAS can promote adaptation to biomechanical stress by modulating cell stiffness (Lin et al., 2015). Here, KRAS is linked to cancer.